Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 5
2006 5
2007 1
2008 1
2009 1
2010 2
2011 3
2012 2
2013 6
2014 5
2015 1
2016 5
2017 3
2018 5
2019 8
2020 7
2021 4
Text availability
Article attribute
Article type
Publication date

Search Results

56 results
Results by year
Filters applied: . Clear all
Page 1
Acute exacerbations of progressive-fibrosing interstitial lung diseases.
Kolb M, Bondue B, Pesci A, Miyazaki Y, Song JW, Bhatt NY, Huggins JT, Oldham JM, Padilla ML, Roman J, Shapera S. Kolb M, et al. Among authors: huggins jt. Eur Respir Rev. 2018 Dec 21;27(150):180071. doi: 10.1183/16000617.0071-2018. Print 2018 Dec 31. Eur Respir Rev. 2018. PMID: 30578331 Free article. Review.
Unexpandable lung from pleural disease.
Huggins JT, Maldonado F, Chopra A, Rahman N, Light R. Huggins JT, et al. Respirology. 2018 Feb;23(2):160-167. doi: 10.1111/resp.13199. Epub 2017 Oct 24. Respirology. 2018. PMID: 29064169 Review.
Response.
Shkolnik B, Judson MA, Austin A, Hu K, D'souza M, Zumbrunn A, Huggins JT, Yucel R, Chopra A. Shkolnik B, et al. Among authors: huggins jt. Chest. 2020 Oct;158(4):1783-1784. doi: 10.1016/j.chest.2020.06.076. Chest. 2020. PMID: 33036094 No abstract available.
The Impact of Gravity vs Suction-driven Therapeutic Thoracentesis on Pressure-related Complications: The GRAVITAS Multicenter Randomized Controlled Trial.
Lentz RJ, Shojaee S, Grosu HB, Rickman OB, Roller L, Pannu JK, DePew ZS, Debiane LG, Cicenia JC, Akulian J, Walston C, Sanchez TM, Davidson KR, Jagan N, Ahmad S, Gilbert C, Huggins JT, Chen H, Light RW, Yarmus L, Feller-Kopman D, Lee H, Rahman NM, Maldonado F; Interventional Pulmonary Outcomes Group. Lentz RJ, et al. Among authors: huggins jt. Chest. 2020 Mar;157(3):702-711. doi: 10.1016/j.chest.2019.10.025. Epub 2019 Nov 9. Chest. 2020. PMID: 31711990 Clinical Trial.
Long-term safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis: results from the open-label extension study, INPULSIS-ON.
Crestani B, Huggins JT, Kaye M, Costabel U, Glaspole I, Ogura T, Song JW, Stansen W, Quaresma M, Stowasser S, Kreuter M. Crestani B, et al. Among authors: huggins jt. Lancet Respir Med. 2019 Jan;7(1):60-68. doi: 10.1016/S2213-2600(18)30339-4. Epub 2018 Sep 14. Lancet Respir Med. 2019. PMID: 30224318 Clinical Trial.
Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis.
Flaherty KR, Fell CD, Huggins JT, Nunes H, Sussman R, Valenzuela C, Petzinger U, Stauffer JL, Gilberg F, Bengus M, Wijsenbeek M. Flaherty KR, et al. Among authors: huggins jt. Eur Respir J. 2018 Aug 2;52(2):1800230. doi: 10.1183/13993003.00230-2018. Print 2018 Aug. Eur Respir J. 2018. PMID: 29946005 Free PMC article. Clinical Trial.
Drug-induced pleural disease.
Huggins JT, Sahn SA. Huggins JT, et al. Clin Chest Med. 2004 Mar;25(1):141-53. doi: 10.1016/S0272-5231(03)00125-4. Clin Chest Med. 2004. PMID: 15062606 Review.
Pleural manometry: techniques, applications, and pitfalls.
Hu K, Chopra A, Huggins JT, Nanchal R. Hu K, et al. Among authors: huggins jt. J Thorac Dis. 2020 May;12(5):2759-2770. doi: 10.21037/jtd.2020.04.04. J Thorac Dis. 2020. PMID: 32642184 Free PMC article. Review.
Routine monitoring with pleural manometry during therapeutic large-volume thoracentesis to prevent pleural-pressure-related complications: a multicentre, single-blind randomised controlled trial.
Lentz RJ, Lerner AD, Pannu JK, Merrick CM, Roller L, Walston C, Valenti S, Goddard T, Chen H, Huggins JT, Rickman OB, Yarmus L, Psallidas I, Rahman NM, Light RW, Maldonado F. Lentz RJ, et al. Among authors: huggins jt. Lancet Respir Med. 2019 May;7(5):447-455. doi: 10.1016/S2213-2600(18)30421-1. Epub 2019 Feb 13. Lancet Respir Med. 2019. PMID: 30772283 Clinical Trial.
56 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page